- Home
- DMAC vs KFS Comparison
DMAC vs KFS Comparison
Compare DMAC & KFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMAC
- KFS
- Stock Information
- Founded
- DMAC 2000
- KFS 1989
- Country
- DMAC United States
- KFS United States
- Employees
- DMAC N/A
- KFS N/A
- Industry
- DMAC Biotechnology: Pharmaceutical Preparations
- KFS Property-Casualty Insurers
- Sector
- DMAC Health Care
- KFS Finance
- Exchange
- DMAC Nasdaq
- KFS Nasdaq
- Market Cap
- DMAC 267.7M
- KFS 223.3M
- IPO Year
- DMAC N/A
- KFS 1996
- Fundamental
- Price
- DMAC $6.51
- KFS $7.66
- Analyst Decision
- DMAC Strong Buy
- KFS
- Analyst Count
- DMAC 3
- KFS 0
- Target Price
- DMAC $7.00
- KFS N/A
- AVG Volume (30 Days)
- DMAC 81.8K
- KFS 23.3K
- Earning Date
- DMAC 03-18-2025
- KFS 03-04-2025
- Dividend Yield
- DMAC N/A
- KFS N/A
- EPS Growth
- DMAC N/A
- KFS N/A
- EPS
- DMAC N/A
- KFS N/A
- Revenue
- DMAC N/A
- KFS $108,627,000.00
- Revenue This Year
- DMAC N/A
- KFS N/A
- Revenue Next Year
- DMAC N/A
- KFS N/A
- P/E Ratio
- DMAC N/A
- KFS N/A
- Revenue Growth
- DMAC N/A
- KFS 2.02
- 52 Week Low
- DMAC $2.14
- KFS $7.60
- 52 Week High
- DMAC $6.82
- KFS $9.58
- Technical
- Relative Strength Index (RSI)
- DMAC 62.22
- KFS 33.79
- Support Level
- DMAC $5.75
- KFS $7.73
- Resistance Level
- DMAC $6.82
- KFS $8.00
- Average True Range (ATR)
- DMAC 0.30
- KFS 0.18
- MACD
- DMAC 0.02
- KFS -0.02
- Stochastic Oscillator
- DMAC 74.48
- KFS 10.17
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
About KFS Kingsway Financial Services Inc. (DE)
Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The firm generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.